Globally, although the vast majority of people have been vaccinated, more people die from TB than from any other infectious disease. Bacille Calmette-Guerin (BCG) is the only commercially available human tuberculosis vaccine.Read More…
High-dose Zika virus Vaccine can protect mothers and infants at the same time
Medical researchers at the University of Texas at Galveston have shown for the first time that a single higher dose of vaccination in a pregnant mouse can safely protect her and herRead More…
Tetravalent Influenza Vaccine approved by FDA in the United States
Recently, the US Food and Drug Administration (FDA) has approved an application for a supplementary biological product license from Sanofi’s Fluzone® High-Dose Quadrivalent (High dose tetravalent, Influenza Vaccine) for older people agedRead More…
Novel Nano-delivery System Makes Vaccine More Effective
1. RNA vaccine RNA-based vaccines have great potential as a way to treat cancer or prevent a variety of infectious diseases. As a result, many biotechnology companies are now developing this typeRead More…
New FDA Breakthrough Drug –Preventive of Respiratory Syncytial Virus (RSV) Advanced Vaccine
Janssen Pharmaceutical recently announced that the US Food and Drug Administration (FDA) has awarded the company the breakthrough drug qualification (BTD) for prophylactic RSV advanced vaccines. It is used to prevent lowerRead More…
Personalized cancer vaccine! Melanoma treatment vaccine TLPLDC reduces the risk of recurrence by 50%
Recently, Elios Therapeutics released positive top-line data to evaluate the clinical trial of TLPLDC (tumor lysate, particle loading, dendritic cell) vaccine in the treatment of melanoma in phase IIb. 1.Research result ThisRead More…
New Vaccine – Fight Two Fatal Respiratory Diseases
Recently, scientists at the Center for Infectious Diseases Research at the University of Adelaide in Australia have developed a single vaccination method. It can simultaneously fight two of the world’s deadliest respiratoryRead More…
HIV Prophylactic Vaccine! Patients in the “Mosaic Vaccine” Efficacy Verification Study Have Been Enrolled in the Study
Johnson (JNJ) of the United States recently announced that patients who evaluated the IIb phase proof-of-concept efficacy study Imbokodo (HVTN 705/HPX2008) of a prophylactic HIV vaccine have been enrolled. The study isRead More…
Sci Rep：Needleless vaccine will protect children from dangerous viruses
Thousands of people die of hepatitis B every year. Children are especially in danger. Because of the high cost and stable environmental conditions required for vaccine storage, many people in developing countriesRead More…
Sci Adv：Nanovaccine can improve immunity of patients with metabolic disorder
In a recent study, Cornell University researchers developed a new class of biomaterials for an infectious disease, nanovaccines, which can effectively improve the immunity of mice with metabolic disorders associated with intestinalRead More…